Skip to Main Content

Paper Details

Initial evaluation of extracorporeal immunomodulatory therapy for the treatment of critically ill COVID-19 infected patients.
Sci Rep
1
2022
Author NameAffiliation
Andrew A HouseSchulich School of Medicine & Dentistry
Andrew A HouseLawson Health Research Institute
  • 1 - 2

Datasets

Release 1.2